Ashland Gains ‘Specialty Core’ with Hercules

Ashland’s $3.3-billion deal to acquire Hercules gives the company its long-sought “specialty core,” says Ashland chairman and CEO James O’Brien. Hercules, with 2007 revenues of $2.1 billion, has leading positions in cellulose esters...

This information is only available to
Chemical Week 24/7 members and subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not a Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive        access of the last 2 years        of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers